CA Stock MarketDetailed Quotes
ARCH Arch Biopartners Inc
- 1.960
- +0.040+2.08%
15min DelayMarket Closed Nov 28 16:00 ET
127.28MMarket Cap-59393P/E (TTM)
1.970High1.950Low3.53KVolume1.970Open1.920Pre Close6.89KTurnover2.56052wk High0.01%Turnover Ratio64.94MShares1.31052wk Low-0.033EPS TTM127.28MFloat Cap5.300Historical HighLossP/E (Static)64.94MShs Float-0.217Historical Low-0.053EPS LYR1.04%Amplitude--Dividend TTM-19.80P/B1Lot Size--Div YieldTTM
Arch Biopartners Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 17.78%1.06M | -67.18%703.25K | 177.42%3M | -246.95%-516.89K | 140.84%474.31K | 112.11%896.03K | 1,867.38%2.14M | 21.14%1.08M | 146.39%351.74K | 120.25%196.94K |
| Selling and administrative expenses | 129.79%429.35K | -61.82%800.18K | 491.44%2.73M | 89.47%195.63K | 152.85%250.31K | 32.58%186.84K | 1,673.18%2.1M | -28.97%461.38K | -17.77%103.25K | -36.29%99K |
| -Selling and marketing expense | -15.37%1.05K | -20.20%1.67K | -63.57%7.19K | 14.19%1.38K | 85.95%2.48K | -52.74%1.24K | -85.62%2.09K | -51.95%19.73K | -94.50%1.21K | -87.39%1.33K |
| -General and administrative expense | 130.76%428.3K | -61.87%798.51K | 516.23%2.72M | 90.36%194.25K | 153.76%247.84K | 34.20%185.6K | 1,920.26%2.09M | -27.42%441.66K | -1.56%102.04K | -32.56%97.67K |
| Research and development costs | -13.46%2.7M | -70.29%135.51K | 52.54%1.94M | -275.50%-1.93M | 918.61%289.33K | 128.39%3.12M | 17.11%456.07K | -66.33%1.27M | -159.18%-513.8K | -96.32%28.4K |
| Other operating expenses | 13.96%-2.08M | 43.21%-232.45K | -156.04%-1.67M | 59.63%1.22M | -193.95%-65.33K | -122.29%-2.42M | -2.66%-409.33K | 81.52%-653.45K | 143.51%762.3K | 103.66%69.54K |
| Operating profit | -17.78%-1.06M | 67.18%-703.25K | -177.42%-3M | 246.95%516.89K | -140.84%-474.31K | -112.11%-896.03K | -1,867.38%-2.14M | -21.14%-1.08M | -146.39%-351.74K | -120.25%-196.94K |
| Net non-operating interest income (expenses) | -17.18%-84.61K | -30.48%-88.7K | -10.69%-342.41K | 4.84%-99.11K | -52.36%-103.12K | -7.72%-72.21K | 3.55%-67.98K | -13.18%-309.33K | -13.13%-104.15K | 28.96%-67.68K |
| Non-operating interest income | --4.07K | ---- | --16.53K | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Non-operating interest expense | 22.81%88.68K | 30.48%88.7K | 16.04%358.94K | 11.03%115.64K | 52.36%103.12K | 7.72%72.21K | -3.55%67.98K | 13.18%309.33K | 13.13%104.15K | -28.96%67.68K |
| Other net income (expenses) | -247.09%-8.55K | -83.59%8.69K | 164.36%11.9K | -311.97%-173.5K | 635.14%126.64K | 230.40%5.82K | 1,042.00%52.94K | -18.49K | -42.12K | 17.23K |
| Gain on sale of security | -247.09%-8.55K | -83.59%8.69K | 164.36%11.9K | -311.97%-173.5K | 635.14%126.64K | 230.40%5.82K | 1,042.00%52.94K | ---18.49K | ---42.12K | --17.23K |
| Income before tax | -19.34%-1.15M | 63.70%-783.25K | -136.30%-3.33M | 149.05%244.28K | -82.21%-450.78K | -97.34%-962.42K | -1,134.77%-2.16M | -20.86%-1.41M | -174.75%-498.01K | -128.20%-247.39K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -19.34%-1.15M | 63.70%-783.25K | -136.30%-3.33M | 149.05%244.28K | -82.21%-450.78K | -97.34%-962.42K | -1,134.77%-2.16M | -20.86%-1.41M | -174.75%-498.01K | -128.20%-247.39K |
| Net income continuous operations | -19.34%-1.15M | 63.70%-783.25K | -136.30%-3.33M | 149.05%244.28K | -82.21%-450.78K | -97.34%-962.42K | -1,134.77%-2.16M | -20.86%-1.41M | -174.75%-498.01K | -128.20%-247.39K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -19.34%-1.15M | 63.70%-783.25K | -136.30%-3.33M | 149.05%244.28K | -82.21%-450.78K | -97.34%-962.42K | -1,134.77%-2.16M | -20.86%-1.41M | -174.75%-498.01K | -128.20%-247.39K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -19.34%-1.15M | 63.70%-783.25K | -136.30%-3.33M | 149.05%244.28K | -82.21%-450.78K | -97.34%-962.42K | -1,134.77%-2.16M | -20.86%-1.41M | -174.75%-498.01K | -128.20%-247.39K |
| Diluted earnings per share | -20.00%-0.018 | 62.86%-0.013 | -130.43%-0.053 | 150.00%0.004 | -75.00%-0.007 | -87.50%-0.015 | -1,066.67%-0.035 | -21.05%-0.023 | -172.73%-0.008 | -128.57%-0.004 |
| Basic earnings per share | -20.00%-0.018 | 62.86%-0.013 | -130.43%-0.053 | 150.00%0.004 | -75.00%-0.007 | -87.50%-0.015 | -1,066.67%-0.035 | -21.05%-0.023 | -172.73%-0.008 | -130.77%-0.004 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data